GlassScriptPhysician profile
Matthew Kirk Steehler
NPI 1164678959
$2,292.60
in general payments reported to CMS, 2019-2025
12 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $12.45 · 2021: $138 · 2022: $123 · 2023: $485 · 2024: $702 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,703.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $604.58 | 2021-2025 | Straightshot, Sinuva, Propel |
| Aerin Medical INC. | $598.11 | 2023-2025 | |
| Inspire Medical Systems, INC. | $560.25 | 2023-2025 | Inspire |
| Acclarent, INC | $128.39 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $115.36 | 2024-2025 | Dupixent |
| Cochlear Americas | $97.60 | 2019 | |
| Novartis Pharmaceuticals Corporation | $57.35 | 2019 | |
| Biomerieux INC | $50.74 | 2025 | Filmarray Torch Module |
| Alk-Abello, INC | $25.98 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $21.65 | 2024 | |
| Intersect Ent, INC. | $17.73 | 2019 | |
| Phadia US INC. | $14.86 | 2024 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Steehler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.